These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2906448)

  • 1. Psychoimmunological dysregulation in multiple sclerosis.
    Foley FW; Miller AH; Traugott U; LaRocca NG; Scheinberg LC; Bedell JR; Lennox SS
    Psychosomatics; 1988; 29(4):398-403. PubMed ID: 2906448
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoregulation in multiple sclerosis.
    Weiner HL; Hauser SL
    Prog Brain Res; 1983; 59():339-43. PubMed ID: 6229809
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual labelling of circulating CD8 cells in patients with multiple sclerosis.
    Hughes PJ; Kirk PF; Compston DA
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):118-21. PubMed ID: 2565378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of T cell subset surface antigen expression in multiple sclerosis.
    Paty DW; Kastrukoff LF
    Prog Clin Biol Res; 1984; 146():119-24. PubMed ID: 6232622
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison between antibody-induced modulation of suppressor cells and suppressor cell changes in multiple sclerosis.
    Antel JP; Oger JJ; Arnason BG
    Trans Am Neurol Assoc; 1981; 106():233-6. PubMed ID: 6217621
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of circulating suppressor inducer T lymphocytes in the exacerbation phase of remitting-relapse multiple sclerosis.
    Cafaro A; Spadaro M; Pandolfi F; Tilia G; Scarselli E; Liberati F; Aiuti F
    Riv Neurol; 1987; 57(3):159-62. PubMed ID: 2960006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor T-lymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease.
    Paty DW; Kastrukoff L; Morgan N; Hiob L
    Ann Neurol; 1983 Oct; 14(4):445-9. PubMed ID: 6227277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of cellular immunity in multiple sclerosis].
    Demina TL; Boĭko AN; Balashov KE; Pinegin BV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):35-41. PubMed ID: 2524943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
    Kumar M; Putzki N; Limmroth V; Remus R; Lindemann M; Knop D; Mueller N; Hardt C; Kreuzfelder E; Grosse-Wilde H
    J Neuroimmunol; 2006 Nov; 180(1-2):178-84. PubMed ID: 17011048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indicators of cellular immunity in patients with multiple sclerosis].
    Dziuba AN; Frolov VM; Gaĭdash IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):12-4. PubMed ID: 1326155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue.
    Sobel RA; Hafler DA; Castro EE; Morimoto C; Weiner HL
    Ann N Y Acad Sci; 1988; 540():306-8. PubMed ID: 2905121
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of suppressor-inducer T-cells in chronic-progressive multiple sclerosis: preliminary results.
    Zaffaroni M; Rossini S; Palma R; Ghezzi A; Marforio S; Cazzullo CL
    Adv Exp Med Biol; 1989; 257():293-5. PubMed ID: 2575849
    [No Abstract]   [Full Text] [Related]  

  • 13. [CD4 and CD8 lymphocyte populations after surgery in hip prosthesis].
    Seyral P; Jamet M; Moghrabi A; Lévy G; François G
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R114. PubMed ID: 2574960
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior of T lymphocytes, T helper and T suppressor, in multiple sclerosis. Preliminary report].
    Tilbery CP; Lima JG; Scheinberg MA; Santos LM; Yamada FT
    Rev Paul Med; 1984; 102(4):181-3. PubMed ID: 6240108
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of immunoregulatory cells and natural killers in the pathogenesis of multiple sclerosis].
    Tunkel' OI; Saidov MZ; Cheredeev AN; Koval'chuk LV; Skriabina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):880-5. PubMed ID: 6224384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper/suppressor ratio in multiple sclerosis.
    Thompson AJ; Brazil JK; Whelan CA; Hutchinson M; Feighery C
    Ir Med J; 1984 Apr; 77(4):119. PubMed ID: 6234258
    [No Abstract]   [Full Text] [Related]  

  • 17. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity.
    Sánchez-Ramón S; Navarro A J; Aristimuño C; Rodríguez-Mahou M; Bellón JM; Fernández-Cruz E; de Andrés C
    Immunol Lett; 2005 Jan; 96(2):195-201. PubMed ID: 15585323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
    Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A
    Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CD8 regulatory T-cells in multiple sclerosis.
    Kreft KL; Verbraak E; Wierenga-Wolf AF; Laman JD; Hintzen RQ
    Ann Neurol; 2011 Mar; 69(3):593; author reply 593-4. PubMed ID: 21400564
    [No Abstract]   [Full Text] [Related]  

  • 20. [Functional properties of T-lymphocytes in patients with multiple sclerosis].
    Zleleznova TA; Ierusalimskiĭ AP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):19-23. PubMed ID: 2529722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.